|
Mar 6
|
ASLAN Pharmaceuticals Announces New Translational Data on Eblasakimab in COPD and Appoints Leading Respiratory Experts as Scientific Advisors
|
|
Jan 2
|
ASLAN Pharmaceuticals Announces Participation in January Investor Conferences
|
|
Oct 27
|
ASLAN Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate Update
|
|
Oct 24
|
ASLAN Pharmaceuticals to Co-Host KOL Panel Discussion Today on Changes in the Clinical Trial and Treatment Landscape for Atopic Dermatitis
|
|
Aug 11
|
ASLAN Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update
|